Pfizer Using Idun Purchase As Model For Future M&A
This article was originally published in The Pink Sheet Daily
Executive Summary
Pfizer is using its acquisition of Idun Pharmaceuticals as a new model for how it looks at M&A: allowing acquired companies to operate independently of Pfizer's big pharma machine